Evidence map›Paper›PMID 35942930›Full record

ArticleEuropean journal of cancer care2022

Delayed urologic cancer care in the COVID-19 pandemic: Patients' experiences.

Hannah Glick, Aashima Sarin, Lindsey A Herrel, Lindsay Ma, Marissa Moore, Inga Van Wieren, Stephanie Chisolm, Diana O'Dell, Ashley Duby, Todd M Morgan and 2 more

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of cancer care, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. The experience of surgical cancer patients during the COVID-19 pandemic at a large cancer centre in London.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Hannah GlickDepartment of Urology, University of Michigan, Ann Arbor, Michigan, USA.ORCID https://orcid.org/0000-0002-1965-3461
Aashima SarinCentral Michigan University College of Medicine, Mount Pleasant, Michigan, USA.
Lindsey A HerrelDepartment of Urology, University of Michigan, Ann Arbor, Michigan, USA.
Lindsay MaDepartment of Urology, University of Michigan, Ann Arbor, Michigan, USA.
Marissa MooreDepartment of Urology, University of Michigan, Ann Arbor, Michigan, USA.
Inga Van WierenDepartment of Urology, University of Michigan, Ann Arbor, Michigan, USA.
Stephanie ChisolmDepartment of Urology, University of Michigan, Ann Arbor, Michigan, USA.
Diana O'DellDepartment of Urology, University of Michigan, Ann Arbor, Michigan, USA.
Ashley DubyDepartment of Urology, University of Michigan, Ann Arbor, Michigan, USA.
Todd M MorganDepartment of Urology, University of Michigan, Ann Arbor, Michigan, USA.
James E MontieDepartment of Urology, University of Michigan, Ann Arbor, Michigan, USA.
Daniela WittmannDepartment of Urology, University of Michigan, Ann Arbor, Michigan, USA.
University of Michigan · USCentral Michigan University · US

Funding

University of Michigan Department of Urology
6 · The paper itself

Abstract

objectiveTo understand experiences of patients with genitourinary cancer who experienced delayed cancer care due to the COVID-19 pandemic.

methodsWe conducted a mixed methods study with an explanatory sequential design. Qualitative findings are reported here. Patients with muscle invasive bladder, advanced prostate or kidney cancer were eligible. Participants were selected for interviews if they self-reported low (0-3/10) or high (6-10/10) levels of distress on a previous survey. Participants were interviewed about their experiences. Interviews were transcribed, coded and categorised using thematic data analysis methodology.

resultsEighteen patients were interviewed. Seven had prostate cancer, six bladder cancer and five kidney cancer. Six themes were derived from the interviews: (1) arriving at cancer diagnosis was hard enough, (2) response to treatment delay, (3) labelling cancer surgery as elective, (4) fear of COVID-19 infection, (5) quality of patient-provider relationship and communication and (6) what could have been done differently.

conclusionThese findings offer insight into the concerns of patients with genitourinary cancers who experienced treatment delays due to COVID-19. This information can be applied to support patients with cancers more broadly, should treatment delays occur in the future.

Indexed as

COVID-19Kidney NeoplasmsUrogenital NeoplasmsUrologic NeoplasmsUrologyHumansMalePandemicsQualitative ResearchCOVID-19genitourinary cancerpsychological distresstreatment delay

Identifiers

PMID35942930
PMCPMC9538597
OpenAlexW4290756139

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.